Business
Bio Spectrum
“Innovation Is Key To Bring Down Cost Of Car-T Therapy In India”
Bengaluru headquartered Syngene International Limited, a global contract research organization, has announced the commissioning of the first phase of its new R&D centre in Hyderabad.
4 min |
April 2020
Bio Spectrum
Top 5 Ways To Tackle The Outbreak
Top 5 Ways To Tackle The Outbreak
2 min |
April 2020
Bio Spectrum
“Indian pharma industry likely to reach $100B and medical devices sector reach $50B by 2025”
INDIA PHARMA AND INDIA MEDICAL DEVICE 2020
3 min |
April 2020
Bio Spectrum
“Council plans to set up Centres of Excellence”
Established in 2014, Life Sciences Sector Skill Development Council (LSSSDC) is a Non-Statutory Skill Certification Body authorized by Ministry of Skill Development and Entrepreneurship, Government of India.
5 min |
April 2020
Bio Spectrum
Marketing with an enticement, not a mallet : content marketing strategies for startups in biotech
Competing against the industry Goliaths that dominate the health and biotech industries can seem like an impossible task for a company in its infancy. Fortunately, small businesses and startups can build a competitive edge by combining innovation with an organized content marketing campaign. Small business owners simply need to be aware of the key challenges they face and combat those challenges through a strategic content marketing campaign aimed at health and biotech customers.
3 min |
April 2020
Bio Spectrum
Karnataka to formulate new policy on Science and Technology
The Government of Karnataka is in the process of bringing out a Science and Technology (S&T) Policy, wherein it is proposing many programmes to support R&D in the state.
1 min |
April 2020
Bio Spectrum
India proposes COVID-19 emergency fund for SAARC countries
Prime Minister Narendra Modi recently interacted with the leaders of the SAARC countries through video conference to chart out a common strategy in order to combat COVID-19 in the region.
1 min |
April 2020
Bio Spectrum
Top 6 Pharma Social Media Break Through in 2019
In a relatively short period of time, social media has reshaped communication for consumers and healthcare professionals alike.
3 min |
February 2020
Bio Spectrum
INDIAN PHARMA UNDER USFDA LENS
India holds a major stake in the US market. Hence US Food Drug Administration (FDA) has imposed stringent regulations to meet the international regulatory requirement which further boosts number of inspections carried out at various facilities on Indian pharmaceutical companies. With the booming generics business, USFDA is keeping a sternwatch over the Indian pharma companies to safeguard the health interest of its population. The government of India has been adopting to stringent mechanisms to ensure the quality of drugs into the market. The Ministry of Health has been imposing a mandatory BA/BE studies for all the pharmaceutical manufacturing permissions. Government’s “Make in India” initiative is expected to deliver more safe, efficient and quality drugs into the market. With these and many more initiatives India will continue to be the powerhouse of pharmaceutical industry in coming years.
6 min |
February 2020
Bio Spectrum
Era of partial replacement of doctors gaining impetus
Technology is assisting healthcare providers to make phenomenal gains by improving outcome in treatments by accurate diagnosis and treatment of diseases. Experts say that technological advancement in healthcare like adoption of digital pathology is expected to be the topmost choice in the healthcare industry, as it has proven to reduce the workload of physicians and clinicians. Additionally, it has also resulted in squeezing down the patient’s expenses due to more systemic approach in health systems enabled by technological developments.
6 min |
February 2020
Bio Spectrum
'We are trying to learn and embrace technology as much as possible'
Novo Nordisk, a global healthcare company has recently appointed Vikrant Shrotriya as its new Managing Director & Corporate Vice President for the India business.
4 min |
February 2020
Bio Spectrum
Keeps Your Risk Factors Under Complete Control
Sartorius introduced the very first Sartocheck ® Filter Integrity Tester in 1980 and over a period spanning more than 3 decades, Sartocheck ® Filter Integrity Tester evolved into an extremely sophisticated automated integrity test solution which is preferred by customers across the globe.
4 min |
Decemeber 2019
Bio Spectrum
Medical devices need separate regulatory framework
Medical devices need separate regulatory framework
5 min |
Decemeber 2019
Bio Spectrum
IVDs – The next big story after pharma
The Indian In Vitro Diagnostics (IVDs) sector, included under the Make-in-India initiative of the Government of India, has huge market potential and is witnessing double-digit growth.
3 min |
Decemeber 2019
Bio Spectrum
INDIGENOUS MEDICAL DEVICE AND DIAGNOSTICS MARKET GROWING AT 6% CROSSES RS 36,000 CRORE
The market of indigenous medical device and diagnostics is estimated at Rs 36,400 crore growing at 6 per cent for 2018-19.
2 min |
Decemeber 2019
Bio Spectrum
Government's Nano approach for pharma industry
Nanotechnology is now known to be the game-changer when it comes dealing with the rising burden of various life-threatening diseases such as cancer, diabetes, cardiovascular diseases along with others.
4 min |
Decemeber 2019
Bio Spectrum
Diagnostic services in India: an untapped potential
With the second-largest population in the world, India also has a massive disease burden which has barred it from enjoying its demographic dividend optimally.
4 min |
Decemeber 2019
Bio Spectrum
Digitization Improves Lab Supply Chain Management
Time is a major obstacle for the invention of a new product or for the development of a novel product from basic concepts. The time taken for an idea to be proved, prototyped and developed into beneficial invention determines the success of the product as there are multiple competitors existing in the market. As a result, scientists have to manage their time efficiently while executing their projects. However, unfortunately a lot of time is wasted when the required lab supplies such as reagents, kits, consumables, equipment etc. are not available while conducting crucial research experiments. Scientists often struggle in contacting the right biosuppliers, establishing trust with a new brand of product or facing delays in the delivery of an urgent material.
9 min |
November 2019
Bio Spectrum
India Announces Major Tax Cuts To Boost Investment
USV Private Limited, an Indian multinational pharmaceutical, and biotechnology company based in Mumbai reacting quickly to the developments and leveraging on the government’s surprise corporate tax rate cut on September 20 announced that it will proceed with its investment of Rs 400 crore on a new state-of-art formulation plant at Vadodara in Gujarat.
5 min |
November 2019
Bio Spectrum
'We Have Developed Over 15000 NCEs This Year'
A leading global Contract Research and Manufacturing Services (CRAMS) company in the area of drug discovery and development, TCG Lifesciences Pvt. Limited started its operations in 2001 in Kolkata and currently has a presence in the United States, Europe, and Japan.
5 min |
November 2019
Bio Spectrum
'PPPs, CoEs Are Needed To Practice Precision Diabetes Care'
Roche Diabetes Care India, a pioneer in the development of diabetes management systems and services, has appointed executive from Novo Nordisk, Omar Sherief Mohammad as the new General Manager for its India business.
5 min |
November 2019
Bio Spectrum
'India's Life Science And Healthcare Industries Are Some Of The Fastest Growing Sectors'
Promega Biotech India Private Ltd, a 100 per cent subsidiary of Promega Corporation USA started its operation in August 2014 in New Delhi has completed five years.
2 min |
September 2019
Bio Spectrum
NDHB - Ambitious But Challenging
The vision of National Digital Health Blueprint (NDHB) is to create a National Digital Health Eco-system that supports Universal Health Coverage in an efficient, accessible, inclusive, affordable, timely and safe manner, through provision of a wide-range of data, information and infrastructure services, duly leveraging open, interoperable, standards-based digital systems, and ensuring the security, confidentiality and privacy of health-related personal information. Although it appears to be a very ambitious project, a large number of obstacles need to be tackled for its successful implementation.
10+ min |
September 2019
Bio Spectrum
'FICCI Heal 2019 - Health Of Healthcare In India'
“No public-private demarcation for the agenda of improving healthcare in India”
2 min |
September 2019
Bio Spectrum
Industrial Enzymes Market Growing At 7% Touches Rs 2360 Crore
The market for enzymes in India was relatively small compared to other sectors but it is picking up as compared to other markets in the world.
6 min |
September 2019
Bio Spectrum
Micronclean Targets Sales Growth For Cleanroom Consumables In India With Biospan Contamination Control Services
In 2017 Micronclean partnered with Biospan to sell its Cleanroom Consumables into the rapidly expanding Indian Pharmaceutical Cleanroom Market. Together they formed a joint venture company Biospan Contamination Control Services so that customers in India could benefit from a product range that has been sold into over 30 countries in the last 5 years.
3 min |
September 2019
Bio Spectrum
Top 10 BioSpectrum Articles of 2016
In a year, BioSpectrum covers a wide array of topics from the life sciences sector which comprises among others biotechnology and allied areas, bio-pharma and pharma, healthcare and med technology etc.
4 min |
January 2017
Bio Spectrum
Strategic HR for Today's Biotech M&As
The pharmaceutical and bio-technology sectors have been witnessing a strong trend of consolidation through mergers and acquisitions (M&A) over the last few years.
5 min |
January 2017
Bio Spectrum
We Are Witnessing a Vibrant and Energetic Business Growth in India
The recent statistics indicate that the Indian pharmaceutical market is currently valued at USD25 billion and is expected to further grow at a CAGR of 12 per cent till 2020. India is the third largest pharmaceutical market in the world by incremental growth and seventh largest by volume, which gives a plethora of opportunities for many life sciences companies. With India’s population expected to reach 1.4 billion in 2022 (as per the 2015 UN Report on World Population), this growing population demands not only large scale production of vaccines but also research for newer vaccines relevant to India and immunotherapy. In order to meet the growing demands of the denizens of the country, Corning Life Sciences, one of the leaders in developing, manufacturing and global supplier of scientific laboratory products for over 100 years, has rolled its sleeves to achieve its goal. Outside of US, India and China are two of the biggest markets for Corning Life Sciences (CLS). In a recent conversation with BioSpectrum, Dr. Richard M. Eglen, Vice President and General Manager, Corning Life Sciences (CLS), and President, Corning International Emerging Market, revealed the expansion plans of CLS and how the company is gearing up to achieve its goal.
3 min |
January 2017
Bio Spectrum
We are excited to be a part of this life sciences Industry
We are excited to be a part of this life sciences Industry
5 min |